Skip to content

Strategies for Improving Linkage-to-Care After Eye Disease Screening

Village Integrated Eye Worker II Linkage-to-Care Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06943599
Enrollment
3000
Registered
2025-04-24
Start date
2026-02-01
Completion date
2028-06-30
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration, Diabetic Retinopathy, Glaucoma

Keywords

Eye Diseases, mass screening, patient compliance, retention in care

Brief summary

The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.

Interventions

Participants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit.

OTHERHealth Worker Visit

Participants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
Seva Foundation
CollaboratorOTHER
National Eye Institute (NEI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Participant of the VIEW II study referred to the eye hospital at their eye screening visit.

Exclusion criteria

* Residence in an area without reliable mobile connectivity

Design outcomes

Primary

MeasureTime frameDescription
Referral Visit Attendance21 days after screeningThe count of participants who attend the referral visit.

Countries

United States

Contacts

CONTACTJeremy Keenan, MD, MPH
jeremy.keenan@ucsf.edu(415) 476-1442
CONTACTKrisianne Aromin
krisianne.aromin@ucsf.edu
PRINCIPAL_INVESTIGATORJeremy Keenan, MD, MPH

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026